Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation

Journal of the American College of Cardiology

Volumn 59, Issue 14, 2012, Pages 1295-1301

  Mohanty, Sanghamitra ^a,c   Mohanty, Prasant ^a   Di Biase, Luigi ^a,b,d   Bai, Rong ^a,e   Pump, Agnes ^a   Santangeli, Pasquale ^a   Burkhardt, David ^a   Gallinghouse, Joseph G ^a   Horton, Rodney ^a,d   Sanchez, Javier E ^a   Bailey, Shane ^a   Zagrodzky, Jason ^a   Natale, Andrea ^a,d,f,g  

^a TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d The University of Texas at Austin   (United States)

^e HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^f STANFORD UNIVERSITY   (United States)

^g SCRIPPS CLINIC   (United States)

Author keywords

atrial fibrillation; CRP; metabolic syndrome

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RECURRENT DISEASE; SHORT FORM 36; THERAPY EFFECT;

AGE FACTORS; AGED; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CATHETER ABLATION; COHORT STUDIES; COMORBIDITY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECURRENCE; REFERENCE VALUES; RISK ASSESSMENT; SEX FACTORS; TACHYCARDIA, PAROXYSMAL; TREATMENT OUTCOME;

EID: 84859149210     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.11.051     Document Type: Article

References (30)

1. S.M. Grundy, H.B. Brewer Jr, J.I. Cleeman, S.C. Smith Jr, C. Lenfant Conference Participants Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition Circulation 109 2004 433 438
2. H. Watanabe, N. Tanabe, T. Watanabe Metabolic syndrome and risk of development of atrial fibrillation: the Niigata Preventive Medicine Study Circulation 117 2008 1255 1260
3. M. Rosiak, M. Dziuba, M. Chudzik Risk factors for atrial fibrillation: not always severe heart disease, not always so "lonely." Cardiol J 17 2010 437 442
4. A. Cheema, C.R. Vasamreddy, D. Dalal Long-term single procedure efficacy of catheter ablation of atrial fibrillation J Interv Card Electrophysiol 15 2006 145 155
5. C. Pappone, S. Rosanio, G. Oreto Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation Circulation 102 2000 2619 2628
6. D. Tziallas, C. Kastanioti, M.S. Kostapanos, P. Skapinakis, M.S. Elisaf, V. Mavreas The impact of the metabolic syndrome on health-related quality of life: a cross-sectional study in Greece Eur J Cardiovasc Nurs 2011 Mar 11 [E-pub ahead of print]
7. R.M. Tanner, U. Baber, A.P. Carson Association of the metabolic syndrome with atrial fibrillation among United States adults (from the Reasons for Geographic and Racial Differences in Stroke [REGARDS] study) Am J Cardiol 108 2011 227 232
8. L. Di Biase, J.D. Burkhardt, P. Mohanty Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation The impact of periprocedural therapeutic international normalized ratio Circulation 121 2010 2550 2556
9. D. Patel, P. Mohanty, L. Di Biase Outcomes and complications of catheter ablation for atrial fibrillation in females Heart Rhythm 7 2010 167 172
10. V. Markides, R.J. Schilling Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment Heart 89 2003 939 943
11. C.J. Boos, R.A. Anderson, G.Y.H. Lip Is atrial fibrillation an inflammatory disorder? Eur Heart J 27 2006 136 149
12. M.S. Spach, P.C. Dolber Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle: evidence for electrical uncoupling of side-to-side fiber connections with increasing age Circ Res 58 1986 356 371
13. E. Raschi, G. Boriani, F. De Ponti Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling Curr Drug Targets 12 2011 263 286
14. K. Umetani, Y. Kodama, T. Nakamura High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome Circ J 71 2007 252 255
15. A. Azevedo, P. Bettencourt, P.B. Almeida Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalitiescross-sectional study of the general population BMC Cardiovasc Disord 7 2007 17
16. W.S. Shin, M.Y. Park, Y.M. Hwang Metabolic syndrome as a risk factor for atrial fibrillation in patients with acute myocardial infarction Korean J Crit Care Med 26 2011 6 12
17. T.J. Wang, H. Parise, D. Levy Obesity and the risk of new-onset atrial fibrillation JAMA 292 2004 2471 2477
18. M. Bhargava, L. Di Biase, P. Mohanty Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study Heart Rhythm 6 2009 1403 1412
19. N.N. Kipshidze, G.A. Katsitadze, L.B. Khosroshvili Effect of the metabolic syndrome on the electrophysiological parameters of the heart Georgian Med News 119 2005 9 13
20. M.M. Oliveira, N. Da Silva, A.T. Timóteo Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation Rev Port Cardiol 26 2007 691 702
21. S. Mohanty, P. Mohanty, L. Di Biase Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation Heart Rhythm 8 2011 1847 1852
22. S.L. Chang, T.C. Tuan, T.C. Tai Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome Am J Cardiol 103 2009 67 72
23. R.B. Tang, J.Z. Dong, X.P. Liu Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation Circ J 73 2009 438 443
24. R.B. Neuman, H.L. Bloom, I. Shukrullah Oxidative stress markers are associated with persistent atrial fibrillation Clin Chem 53 2007 1652 1657
25. K.P. Letsas, R. Weber, G. Brkle Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation Europace 11 2009 158 163
26. Y.J. Lin, H.M. Tsao, S.L. Chang Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation Am J Cardiol 105 2010 495 501
27. A. Erdogan, J. Carlsson, T. Neumann Quality-of-life in patients with paroxysmal atrial fibrillation after catheter ablation: results of long-term follow-up Pacing Clin Electrophysiol 26 2003 678 684
28. K. Yaffe, A. Kanaya, K. Lindquist The metabolic syndrome, inflammation, and risk of cognitive decline JAMA 292 2004 2237 2242
29. A. Wokhlu, K.M. Monahan, D.O. Hodge Long-term quality of life after ablation of atrial fibrillation: the impact of recurrence, symptom relief, and placebo effect J Am Coll Cardiol 55 2010 2308 2316
30. R.D. Goldney, P.J. Phillips, L.J. Fisher, D.H. Wilson Diabetes, depression, and quality of life: a population study Diabetes Care 27 2004 1066 1070